🇺🇸 LODOXAMIDE TROMETHAMINE in United States

11 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 2 reports (18.18%)
  2. Abnormal Sensation In Eye — 1 report (9.09%)
  3. Anaemia Macrocytic — 1 report (9.09%)
  4. Anxiety — 1 report (9.09%)
  5. Choking Sensation — 1 report (9.09%)
  6. Completed Suicide — 1 report (9.09%)
  7. Cough — 1 report (9.09%)
  8. Dilatation Atrial — 1 report (9.09%)
  9. Electrocardiogram Qrs Complex Prolonged — 1 report (9.09%)
  10. Electrocardiogram Qt Prolonged — 1 report (9.09%)

Source database →

LODOXAMIDE TROMETHAMINE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is LODOXAMIDE TROMETHAMINE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for LODOXAMIDE TROMETHAMINE in United States?

Marketing authorisation holder not available in our data.